000 04070nam a22003615i 4500
001 287659
003 MX-SnUAN
005 20160429154556.0
007 cr nn 008mamaa
008 150903s2013 xxk| o |||| 0|eng d
020 _a9781447141327
_99781447141327
024 7 _a10.1007/9781447141327
_2doi
035 _avtls000339730
039 9 _a201509030318
_bVLOAD
_c201404300404
_dVLOAD
_y201402060942
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC681-688.2
100 1 _aRajamannan, Nalini M.
_eeditor.
_9316951
245 1 0 _aCardiac Valvular Medicine /
_cedited by Nalini M. Rajamannan.
264 1 _aLondon :
_bSpringer London :
_bImprint: Springer,
_c2013.
300 _axiii, 254 páginas 114 ilustraciones, 97 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _a1.Natural History of Aortic Valve Stenosis -- 2. Cardiovascular Risk Factors for Calcific Aortic Valve Disease -- 3.Bicuspid Aortic Valve Disease: From Bench to Bedside -- 4.Experimental Evidence for the Role of Atherosclerosis in Calcific Aortic Valve Disease -- 5.The Electrocardiogram as a Risk Predictor in Asymptomatic Aortic Stenosis -- 6.Exercise Testing in Aortic Stenosis and in Mitral Regurgitation -- 7. Detection of Calcium in the Aortic Valve by Non- Invasive Imaging -- 8.Assessment of Aortic Stenosis Severity:Determining Timing to Surgery -- 9.Balloon Aortic Valvuloplasty -- 10.Imaging for TAVI -- 11.Transcutaneous Aortic Valve Implantation -- 12.Role of statins in valvular heart disease: Rheumatic valve disease and bioprosthetic valves -- 13.Slowing the Progression of Aortic Stenosis – The Emerging Role of Bisphosphonates -- 14.LDL-Density-Theory:Implications for Future Clinical Trials -- 15.Infective Endocarditis: New Recommendations and Perspectives -- 16.Assessment and Timing to Intervention of Mitral Regurgitation -- 17. Biology of Mitral Valve Disease -- 18.Mitral Valve Devices -- 19.Anatomy and Pathology of Right-sided atrioventricular and semilunal valves -- 20.Mechanisms, Evaluation and Management of Tricuspid Regurgitation.
520 _aExperimental studies in the field of cardiac valve biology are now demonstrating that the cardiac valve disease process is an active biology with risk factors analogous to vascular risk factors.  Understanding the risk factors is also evolving rapidly, giving physicians and scientists insight into the cellular mechanisms and raising the possibility of treating these valve lesions with other options besides surgical valve repair. Our knowledge of right-sided valve lesions is also rapidly becoming important in the field of valvular medicine. Not only is the pathology different from left-sided valve lesions, but the hemodynamic compromise is more complex and difficult to treat in patients who develop tricuspid or pulmonic valve disease. Early diagnosis and careful management of this patient population is critical for long term outcomes in this patient population.   Cardiac Valvular Medicine represents an overview of the most recent science, clinical trials and new discoveries in the field of valvular heart disease. The editor has assembled a team of highly experienced contributors to provide a thorough translational understanding of the current and future treatments for this patient population. Cardiologists, internists, family practice physicians, cardiac surgeons and basic scientists will all find enormous benefit from this textbook.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781447141310
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4471-4132-7
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c287659
_d287659